USA FDA has accepted Sandoz application for biosimilar filgrastim

On the 24th July 2014 Sandoz announced that the USA FDA has accepted Sandoz application for biosimilar filgrastim.

Comments Off on USA FDA has accepted Sandoz application for biosimilar filgrastim